compounded semaglutide vs brand name comparison Best Online Compounding Pharmacy: 5 Providers Compared (2026) Omzo GLP-1 Review 2026: Is

Heres the realistic timeline: Phase 3 trials (AMAZE program): - AMAZE 1 (obesity) started February 2026, enrolling ~1,150 participants - Primary completion estimated: June 2029 - Phase 3 in T2D also being planned following the ADA 2026 data US FDA approval (projected): Q4 2030 at the earliest (GlobalData estimate) EU EMA approval (projected): Q1 2031 at the earliest Bulgaria and Eastern Europe: Typically 612 months after EMA approval for market access, depending on national reimbursement negotiations

Step 3 Approval, Payment, and Program Enrollment If the provider determines a prescription is appropriate, the patient receives an approval notification and completes payment for their program

[DOI] [PubMed] [Google Scholar] 15.Naeem M, Imran L, Banatwala UESS

Please note: This FAQ is general guidance only

If you have questions about a missed dose or concerns about your dosing schedule, contact your healthcare provider or pharmacist for personalized guidance